Predictive model of venous thromboembolism in endometrial cancer

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma

“…The cutoff for thrombocytosis (platelet count ≥400 ×10 9 /L) was determined on the basis of prior work. 18 Among those with recurrent or progressive disease, CA-125 levels and platelet counts were also collected at the time of first recurrence or progression. For survival outcomes, we determined progression-free survival (PFS) and overall survival (OS).…”

Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer

“…The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines were consulted for reporting in a retrospective cohort study [16]. Some of the patients in this study were within the context of our previous studies [17][18][19][20].…”

“…The cutoff values for complete blood counts were based on the previous studies for endometrial cancer: Neutrophil-to-lymphocyte ratio (N/L ratio, defined as the proportional ratio of absolute neutrophil counts over lymphocyte counts) of 3.0 [21], hemoglobin of 12.0 g/dL [22], and platelet of 400 × 10 9 /L [20]. Because no prior study examined the significance of monocyte counts on endometrial cancer survival, monocyte counts were categorized into three groups (1%-33%ile ≤0.4, 34%-66%ile 0.5-0.6, and 67%-100%ile, ≥ 0.7 × 10 9 /L).…”

Thromboprophylaxis in women undergoing gynecological surgery or assisted reproductive techniques: new advances and challenges

“…Early thromboembolic events are related to surgery and chemotherapy, whereas later VTE incidences were linked to older age, prior history of DVT, FIGO stage IIC-IV, and presence of residual tumor after initial surgery [22]. Moreover, the risk of VTE depends also on the histological subtypes of carcinomas and for example, the clear cell tumor is associated with the highest VTE incidence of 11-27% [23].…”

“…So far the relationship between the histological type of uterine cancer and VTE in unclear [26]. However, Matsuo et al indicated that uterine serous carcinoma (type 2 endometrial cancer) was the most common histologic subtype associated with VTE [23].…”